{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T08:29:18Z","timestamp":1656318558283},"reference-count":12,"publisher":"Medwave Estudios Limitada","issue":"Suppl3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medwave"],"DOI":"10.5867\/medwave.2016.6545","type":"journal-article","created":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T09:15:18Z","timestamp":1475486118000},"page":"e6545-e6545","source":"Crossref","is-referenced-by-count":2,"title":["Cabergoline or bromocriptine for prolactinoma?"],"prefix":"10.5867","volume":"16","author":[{"given":"Nicol\u00e1s","family":"Triantafilo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Castro-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Rada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3888","published-online":{"date-parts":[[2016,9,15]]},"reference":[{"issue":"3","key":"ref0","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s11102-010-0290-z","article-title":"Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis.","volume":"14","author":"dos Santos Nunes","year":"2011","unstructured":"dos Santos Nunes V, El Dib R, Boguszewski CL, Nogueira CR. Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis. Pituitary. 2011 Sep;14(3):259-65. | CrossRef | PubMed |","journal-title":"Pituitary","ISSN":"http:\/\/id.crossref.org\/issn\/1386-341X","issn-type":"print"},{"issue":"7","key":"ref1","first-page":"505","article-title":"Treatment of hyperprolactinemia: a systematic review and meta-analysis. Syst Rev. 2012 Jul 24;1:33. | CrossRef | PubMed | Al-Husaynei AJ, Mahmood IH, Al-Jubori ZS. Comparison of the effects of cabergoline and bromocriptine in women with hyperprolactinemic amenorrhea. Middle East Fertility Society Journal. 2008;3(1):33-38. | Link | Bahceci M, Sismanoglu A, Ulug U. Comparison of cabergoline and bromocriptine in patients with asymptomatic incidental hyperprolactinemia undergoing ICSI-ET.","volume":"26","author":"Wang","year":"2010","unstructured":"Wang AT, Mullan RJ, Lane MA, Hazem A, Prasad C, Gathaiya NW, et al. Treatment of hyperprolactinemia: a systematic review and meta-analysis. Syst Rev. 2012 Jul 24;1:33. | CrossRef | PubMed | Al-Husaynei AJ, Mahmood IH, Al-Jubori ZS. Comparison of the effects of cabergoline and bromocriptine in women with hyperprolactinemic amenorrhea. Middle East Fertility Society Journal. 2008;3(1):33-38. | Link | Bahceci M, Sismanoglu A, Ulug U. Comparison of cabergoline and bromocriptine in patients with asymptomatic incidental hyperprolactinemia undergoing ICSI-ET. Gynecol Endocrinol. 2010 Jul;26(7):505-8. | CrossRef | PubMed |","journal-title":"Gynecol Endocrinol","ISSN":"http:\/\/id.crossref.org\/issn\/0951-3590","issn-type":"print"},{"issue":"3","key":"ref2","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1530\/eje.0.1380286","article-title":"Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine.","volume":"138","author":"De Rosa","year":"1998","unstructured":"De Rosa M, Colao A, Di Sarno A, Ferone D, Landi ML, Zarrilli S, et al. Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine. Eur J Endocrinol. 1998 Mar;138(3):286-93. | PubMed |","journal-title":"Eur J Endocrinol","ISSN":"http:\/\/id.crossref.org\/issn\/0804-4643","issn-type":"print"},{"issue":"11","key":"ref3","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1210\/jcem.86.11.8054","article-title":"Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy.","volume":"86","author":"Di Sarno","year":"2001","unstructured":"Di Sarno A, Landi ML, Cappabianca P, Di Salle F, Rossi FW, Pivonello R, et al. Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy. J Clin Endocrinol Metab. 2001 Nov;86(11):5256-61. | PubMed |","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"3","key":"ref4","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1210\/jcem.83.3.4674","article-title":"Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males.","volume":"83","author":"Di Somma","year":"1998","unstructured":"Di Somma C, Colao A, Di Sarno A, Klain M, Landi ML, Facciolli G, et al. Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males. J Clin Endocrinol Metab. 1998 Mar;83(3):807-13. | PubMed |","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"2","key":"ref5","first-page":"255","article-title":"Comparative effects of bromocriptine and cabergoline on serum prolactin levels, liver and kidney function tests in hyperprolactinemic women.","volume":"26","author":"Mahmood","year":"2010","unstructured":"Mahmood IH, Al-Husaynei AJ, Mohamad SH. Comparative effects of bromocriptine and cabergoline on serum prolactin levels, liver and kidney function tests in hyperprolactinemic women. Pakistan Journal of Medical Sciences Online.2010;26(2):255-260. | Link |","journal-title":"Pakistan Journal of Medical Sciences Online"},{"key":"ref6","first-page":"670","article-title":"A comparison of bromocriptine & cabergoline on fertility outcome of hyperprolactinemic infertile women undergoing intrauterine insemination.","volume":"131","author":"Motazedian","year":"2010","unstructured":"Motazedian S, Babakhani L, Fereshtehnejad SM, Mojthahedi K. A comparison of bromocriptine & cabergoline on fertility outcome of hyperprolactinemic infertile women undergoing intrauterine insemination. Indian J Med Res. 2010 May;131:670-4. | PubMed |","journal-title":"Indian J Med Res","ISSN":"http:\/\/id.crossref.org\/issn\/0971-5916","issn-type":"print"},{"issue":"16","key":"ref7","first-page":"753","volume":"24","author":"Pascal-Vigneron","year":"1995","unstructured":"Pascal-Vigneron V, Weryha G, Bosc M, Leclere J. [Hyperprolactinemic amenorrhea:treatment with cabergoline versus bromocriptine. Results of a national multicenter randomized double-blind study]. Presse Med. 1995 Apr 29;24(16):753-7. | PubMed |","journal-title":"Presse Med","ISSN":"http:\/\/id.crossref.org\/issn\/0755-4982","issn-type":"print"},{"issue":"9","key":"ref8","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1210\/jc.85.9.3053","article-title":"Primary medical therapy of micro- and macroprolactinomas in men.","volume":"85","author":"Pinzone","year":"2000","unstructured":"Pinzone JJ, Katznelson L, Danila DC, Pauler DK, Miller CS, Klibanski A. Primary medical therapy of micro- and macroprolactinomas in men. J Clin Endocrinol Metab. 2000 Sep;85(9):3053-7. | PubMed |","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"9","key":"ref9","doi-asserted-by":"publisher","first-page":"857","DOI":"10.2169\/internalmedicine.40.857","article-title":"Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients.","volume":"40","author":"Sabuncu","year":"2001","unstructured":"Sabuncu T, Arikan E, Tasan E, Hatemi H. Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients. Intern Med. 2001 Sep;40(9):857-61. | PubMed |","journal-title":"Intern Med","ISSN":"http:\/\/id.crossref.org\/issn\/0918-2918","issn-type":"print"},{"issue":"5","key":"ref10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/BF03350694","article-title":"Osteocalcin levels in patients with microprolactinoma before and during medical treatment.","volume":"13","author":"Sartorio","year":"1990","unstructured":"Sartorio A, Conti A, Ambrosi B, Muratori M, Morabito F, Faglia G. Osteocalcin levels in patients with microprolactinoma before and during medical treatment. J Endocrinol Invest. 1990 May;13(5):419-22. | PubMed |","journal-title":"J Endocrinol Invest","ISSN":"http:\/\/id.crossref.org\/issn\/0391-4097","issn-type":"print"},{"issue":"2","key":"ref11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of yperprolactinemia: an Endocrine Society clinical practice guideline.","volume":"96","author":"Webster","year":"2011","unstructured":"Webster J, Piscitelli G, Polli A, Ferrari CI, Ismail I, Scanlon MF. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group. N Engl J Med. 1994 Oct 6;331(14):904-9. | PubMed | Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, et al. Diagnosis and treatment of yperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011 Feb;96(2):273-88. | CrossRef | PubMed |","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"}],"container-title":["Medwave"],"original-title":["\u00bfCabergolina o bromocriptina para el prolactinoma?"],"link":[{"URL":"https:\/\/www.medwave.cl\/link.cgi\/Medwave\/PuestaDia\/ResEpis\/6545","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T11:57:10Z","timestamp":1562846230000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medwave.cl\/link.cgi\/Medwave\/PuestaDia\/ResEpis\/6545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,15]]},"references-count":12,"journal-issue":{"issue":"Suppl3","published-online":{"date-parts":[[2016,9,15]]}},"URL":"https:\/\/doi.org\/10.5867\/medwave.2016.6545","relation":{},"ISSN":["0717-6384"],"issn-type":[{"value":"0717-6384","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,15]]}}}